|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,105,540 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
17,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,919,264 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Weber David M |
Chief Operating Officer |
|
2017-07-31 |
4 |
OE |
$10.03 |
$165,495 |
D/D |
16,500 |
125,122 |
|
- |
|
Tomsicek Michael John |
Vice President, CFO |
|
2017-07-15 |
4 |
D |
$145.07 |
$569,400 |
D/D |
(3,925) |
27,081 |
|
- |
|
Sutter Martin P |
Director |
|
2017-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
117 |
164,843 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-05-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
37,069 |
124,380 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-05-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
37,069 |
168,933 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-24 |
4 |
OE |
$22.44 |
$224,400 |
D/D |
10,000 |
56,757 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2017-05-24 |
4 |
D |
$134.74 |
$211,677 |
D/D |
(1,571) |
64,630 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-05-24 |
4 |
D |
$134.74 |
$1,025,641 |
D/D |
(7,612) |
205,941 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2017-05-24 |
4 |
D |
$134.74 |
$273,792 |
D/D |
(2,032) |
108,622 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2017-05-24 |
4 |
D |
$134.74 |
$211,677 |
D/D |
(1,571) |
60,313 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-24 |
4 |
D |
$134.74 |
$211,677 |
D/D |
(1,571) |
46,757 |
|
- |
|
Tomsicek Michael John |
Vice President, CFO |
|
2017-05-24 |
4 |
D |
$134.74 |
$211,138 |
D/D |
(1,567) |
34,931 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-16 |
4 |
AS |
$133.64 |
$518,390 |
D/D |
(3,879) |
48,328 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,434 |
110,654 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2017-05-15 |
4 |
D |
$131.42 |
$696,657 |
D/D |
(5,301) |
97,220 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,998 |
61,884 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2017-05-15 |
4 |
A |
$131.42 |
$588,367 |
D/D |
4,477 |
51,886 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,998 |
52,207 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-15 |
4 |
D |
$131.42 |
$722,284 |
D/D |
(5,496) |
42,209 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-15 |
4 |
AS |
$133.15 |
$1,923,037 |
D/D |
(14,400) |
47,705 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2017-05-15 |
4 |
OE |
$22.44 |
$323,136 |
D/D |
14,400 |
62,105 |
|
- |
|
Tomsicek Michael John |
Vice President, CFO |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,698 |
36,498 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,198 |
66,201 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2017-05-15 |
4 |
D |
$131.42 |
$587,842 |
D/D |
(4,473) |
56,003 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
51,383 |
240,076 |
|
- |
|
740 Records found
|
|
Page 17 of 30 |
|
|